CN104840905A - Traditional Chinese medicine capsule for treating non-small cell lung cancer - Google Patents
Traditional Chinese medicine capsule for treating non-small cell lung cancer Download PDFInfo
- Publication number
- CN104840905A CN104840905A CN201510322226.8A CN201510322226A CN104840905A CN 104840905 A CN104840905 A CN 104840905A CN 201510322226 A CN201510322226 A CN 201510322226A CN 104840905 A CN104840905 A CN 104840905A
- Authority
- CN
- China
- Prior art keywords
- parts
- lung cancer
- radix
- cell lung
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to a traditional Chinese medicine capsule for treating non-small cell lung cancer, belonging to the technical field of Chinese herbal medicine prescriptions for treating the non-small cell lung cancer. Based on research and therapeutic principle of traditional medical science on lung cancer pathogenesis, the traditional Chinese medicine capsule is used for treating non-small cell lung cancer by using comprehensive synergistic effects of 22 raw medical materials such as radix astragali, dangshen and white atractylodes rhizome, adjutsing functions of viscus, yin and yang, qi and blood as well as channels and collaterals of the whole body, suppressing proliferation of cancer cells, inducing apoptosis of the cancer cells, further enhancing immunity of the patient body and improves body adaptability of the patient, thereby resisting to cancer of the patient and improving immunity. The functions of viscus, yin and yang, qi and blood as well as channels and collaterals of the whole body are conditioned in all aspects, the so-called theory of keeping healthy qi inside is realized, and self-regulation is carried out to release the surplus and make up a deficiency as well as realize balance of yin and yang, so that the original hypractive cancer tumor angiogenesis is suppressed, and the traditional Chinese medicine capsule is good for reducing local blood supply of a tumor tissue and preventing generation and development of the tumor.
Description
Technical field
The present invention relates to a kind of Chinese medicinal capsule for the treatment of nonsmall-cell lung cancer, belong to the Chinese herbal medicine preparation technology field for the treatment of nonsmall-cell lung cancer.
Background technology
Primary bronchogenic carcinoma of lung becomes the malignant tumor that sickness rate is the highest in the world, and human health and life in serious threat, wherein has the sufferer of 80% ~ 85% to be nonsmall-cell lung cancer.Pulmonary carcinoma is put under " lump in the right hypochondrium " category in the traditional Chinese medical science, its pathogenesis is " healthy energy virtual loss, cancer poison damages network; network void is exerted a pernicious influence ", think that inside and outside poison is evil to interact for a long time, the positive deficiency of vital energy declines in addition, anti-heresy is unable, and evil poison resides in channels, lose network removing toxic substances, the high change of network poison, high evil, without system, is changed main new network silt resistance and is gathered formation pulmonary carcinoma.The network of new life is also for network poison pents up part, and network poison is with network slime flux, and interior impairment of ZANG FU-organs, reaches podomere outward, forms metastasis, and damage internal organs, ruin body passages through which vital energy circulates.The visible resistance lung network that becomes silted up, the high change of network poison be pulmonary carcinoma formed and one of the important pathogenesis.
Mainly adopting at present the method treatment nonsmall-cell lung cancer of chemotherapy clinically, mainly adopt two cycle GP(gemcitabine+platinum classes) scheme carries out chemotherapy.But simple chemotherapy effective percentage is lower, toxicity is comparatively large and medical expense is higher.
Summary of the invention
The object of the invention is to, for the deficiency of above-mentioned existing treatment nonsmall-cell lung cancer method, there is provided a kind of to be formed by traditional Chinese medicine, for the pathogeny of nonsmall-cell lung cancer, the function of the internal organs of integrated regulation body, negative and positive, QI and blood and meridians, hyperfunction tumor-blood-vessel growth is suppressed, increases chemotherapeutic efficacy, alleviate the Chinese medicinal capsule of the treatment nonsmall-cell lung cancer of chemotherapy toxic side effect.
The present invention realizes above-mentioned purpose by the following technical solutions:
Treat a Chinese medicinal capsule for nonsmall-cell lung cancer, it is characterized in that: it is made up of the raw material of following weight parts:
The Radix Astragali 50 parts, Radix Codonopsis 20 parts, the Rhizoma Atractylodis Macrocephalae 15 parts,
15 parts, Poria, 15 parts, Fructus Jujubae, Ganoderma 30 parts,
Fructus Aurantii 12 parts, Semen Cuscutae 15 parts, Fructus Ligustri Lucidi 15 parts,
Fructus Lycii 15 parts, Endothelium corneum 30 parts, Semen Coicis 30 parts,
10 parts, Radix Glycyrrhizae, Herba Scutellariae Barbatae 30 parts, Rhizoma Sparganii 30 parts,
Rhizoma Curcumae 30 parts, Scolopendra 10 parts, Gekko Swinhonis 10 parts,
Radix Semiaquilegiae 15 parts, Herba Selaginellae Doederleinii 15 parts, Pseudobulbus Cremastrae Seu Pleiones 15 parts,
Herba Hedyotidis Diffusae 30 parts.
In above-mentioned prescription: the Radix Astragali, Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Poria, Fructus Jujubae is monarch drug; Ganoderma, Fructus Aurantii, Semen Cuscutae, Fructus Ligustri Lucidi, Fructus Lycii, Endothelium corneum, Semen Coicis, Herba Hedyotidis Diffusae, Herba Scutellariae Barbatae, Rhizoma Sparganii, Rhizoma Curcumae is ministerial drug; Scolopendra, Gekko Swinhonis, Radix Semiaquilegiae, Herba Selaginellae Doederleinii, Pseudobulbus Cremastrae Seu Pleiones is adjuvant drug; Radix Glycyrrhizae is for making medicine.
Technical solution of the present invention, to the research of lung cancer morbidity mechanism and Therapeutic Principle based on motherland's medical science, from the function of the internal organs of integrated regulation body, negative and positive, QI and blood and meridians, accomplish that what is called " is kept in healthy energy ", pass through self-regulation, " reducing for the excess syndrome, tonifying for deficiency syndrome ", reaches the effect of " negative and positive are calmed down ".
In the material component that the present invention is above-mentioned, pharmacology and the drug effect of every component raw material are:
The Radix Astragali: sweet, tepor.Return lung, spleen, liver, kidney channel.Exterior deficiency spontaneous perspiration, night sweat due to yin deficiency, acute nephritis edema, oedema due to chronic nephritis, spleen are suffered from a deficiency of the kidney, yang-energy weak." Elementary Medicine book on Chinese herbal medicine ": grey black arrogant person's forbidding, prosperous person is also unavailable for table excess pathogen, and deficiency of YIN person also should use less.
Radix Codonopsis: flat, sweet.Air making-up and spleen enlivening." herbal classic is met former ": lung heat clearing.Shangdang Radix Ginseng, though without the merit of the high benefit of sweet temperature, have the power of sweet flat lung heat clearing, does not also specially let out lung qi also like the cold in nature of Radix Adenophorae (Radix Glehniae).
The Rhizoma Atractylodis Macrocephalae: bitter, sweet, temperature.Return spleen, stomach warp.Invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive." medicine origin " is recorded: dehumidifying benefit is dry, and middle QI invigorating, warming middle-JIAO, and go in taste wet, except gastric heat, strong taste, enter diet, antiabortive.
Poria: sweet, light, property is put down.GUIXIN, lung, spleen, kidney channel.Promoting diuresis to eliminate damp pathogen, spleen invigorating, mind calming.Amplification on Canon of Materia Medica: Poria, Poria cum Radix Pini, the merit of row water is many, heart-spleen boosting can not fault also.
Fructus Jujubae: sweet, warm.Return spleen, stomach warp.Invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind.
Patients with lung cancer mostly is vital QI being weakened and pathogen being violent, through > cloud in <; " the gathering of heresy, its gas must be empty ".Healthy energy virtual loss, void is not driven evil, and with the passing of time, the stagnation of QI, blood stasis, expectorant are tied, it is poly-to wet, pyretic toxicity is entangled with mutually, and with the passing of time stagnate and the lump of materialize, become cancer, cancer is just also being hindered, healthy energy loss in heresy love, therefore the our rule for the treatment of is substantially: righting QI invigorating, eliminating evil counteracting toxic substances.The above-mentioned Radix Astragali, Radix Codonopsis invigorating the lung and benefiting vital QI; The Rhizoma Atractylodis Macrocephalae, Poria, the large benefit of Fructus Jujubae invigorating the spleen and benefiting QI " the foundation of acquired constitution ", embody the rule for the treatment of of " building up the spleen to supplement the lung ", " reinforcing the mother-organ for treating deficiency of the son-organ ", and reach in healthy energy deposits, heresy can not be done.Therefore be monarch drug.
Ganoderma: temperature, light.Malaise, insomnia, palpitation with fear, cough with asthma abundant expectoration, consumptive disease.Shennong's Herbal: " Ganoderma lucidum (Leyss. Ex Fr.) Karst., bitter in the mouth is put down.Master ties in the heart, the beneficial motive, invigorating middle warmer, increases
Intelligence, does not forget.Food of a specified duration, make light of one's life by commiting suicide not old, prolong life angle.A Ganoderma lucisum.
Fructus Aurantii: bitter, pungent, sour, warm.Dispelling the stagnated QI, row expectorant, removing food stagnancy.Control chest and diaphragm expectorant stagnant, the feeling of stuffiness in chest, coerce swollen, food stagnation, eructation, vomiting, " pearl sac ": dispelling the stagnated QI, let out gas unfavorable in lung.
Semen Cuscutae: temperature, sweet.Return liver,kidney,spleen warp.Nourishing the liver and kidney, controlling nocturnal emission with astringent drugs reducing urination, antiabortive, tomorrow, antidiarrheal." property of medicine opinion ": " control man woman cold caused by deficiency, sperm adding and marrow healthing, go pain in the lumbar region knee joint cold, master quenches one's thirst and hankers again."
Fructus Ligustri Lucidi: sweet, bitter, cold.Return liver, kidney channel.Liver and kidney tonifying, improving eyesight, clearind deficient heat " Bencao Jingshu " is carried: " Fructus Ligustri Lucidi, abnormal smells from the patient is all cloudy, and just entering kidney except what vulcanize essence and wanting product, kidney must be mended, then the five internal organs are from peace, and spirit is self-sustaining, and all kinds of diseases and ailments are gone and body is fertile is good for."
Fructus Lycii: sweet, flat.Return liver, kidney channel.Nourishing the liver, nourishing kidney, lung moistening.
Endothelium corneum: sweet is flat.Return spleen, stomach, small intestinal, urinary bladder channel.Invigorating the stomach and promoting digestion, arresting seminal emission, treating stranguria fossil." young new book of living ": all aphthas: Endothelium Corneum Gigeriae Galli ashing applies it, has immediate effect.
Semen Coicis: cool in nature is sweet in the mouth, light.Return stomach, lung, spleen channel.Rheumatism body aches, and the sunset aggravates.Edema dyspnea with rapid respiration.Sandstone pyretic stranguria.
Herba Hedyotidis Diffusae: micro-hardship, cold.Return stomach, large intestine, small intestine meridian.Heat-clearing and toxic substances removing, medicinal powder for relieving pain knot, promoting urination to remove dampness.
Herba Scutellariae Barbatae: acrid in the mouth, hardship.Return lung, liver, kidney channel.Heat-clearing and toxic substances removing, blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, anticancer effect.
Rhizoma Sparganii: pungent, bitter.Return liver, spleen channel.Removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving.Compendium of Material Medica: logical Liver Channel hematocele, woman's moon water, puerperal stagnant blood.
Rhizoma Curcumae: pungent, bitter, temperature.Return liver, spleen channel.Removing blood stasis circulation of qi promoting, removing food stagnancy pain relieving.Promoting the circulation of QI to relieve pain, removing blood stasis removing food stagnancy, promoting digestion and removing stagnation.
Patients with lung cancer vital QI being weakened and pathogen being violent, pathogen mostly is the stagnation of QI, blood stasis, expectorant knot, wet poly-, pyretic toxicity are entangled with mutually, above-mentioned Fructus Ligustri Lucidi, Fructus Lycii, Ganoderma Replenishing QI and nourishing YIN; Semen Cuscutae temperature male wind-supplying kidney, gets treating YIN within YANG, yin yang complementarity, and Semen Coicis is dispelled heat clearing away, invigorating the spleen for dissipating phlegm, wet; Rhizoma Sparganii, Rhizoma Curcumae blood stasis dispelling become whole blood viscosity after changing life quality treatment, reduce transfer, promote that Chinese medicine medicine for preventing immunologically competent cell enters tumor body, thus reach the anticancer effect with improving immunity; Endothelium corneum has effect of hard masses softening and resolving, Fructus Aurantii promoting QI circulation for relieving depression.Herba Scutellariae Barbatae, Herba Hedyotidis Diffusae have heat-clearing and toxic substances removing, and heresy attacked by Eradicates poison.And modern medicine study shows, above-mentioned two medicines, have antitumaous effect.Above-mentioned all medicine circulation of qi promoting, resolving depression, blood stasis dispelling, dampness, reduce phlegm, heat clearing away, removing toxic substances, and reinforcement and elimination in combination, is not eliminating evilly just hindering, and is ministerial drug altogether.
Scolopendra: pungent, temperature; Poisonous.Return liver, heart channel." detailed outline ": moderns only process with fire, sufficient use of decaptitating, or the foot that truncates, simmer with mentha leave fire and use it.
Gekko Swinhonis: salty, cold.Slightly poisonous.Enter kidney, liver two warp." Traditional Chinese Medicine in Sichuan will ": wind dispelling, removing blood stasis amasss enclosed mass, controls and swells and ache.
Radix Semiaquilegiae: bitter; Micro-pungent; Cold in nature; Mild toxicity.Return liver; Spleen; Urinary bladder channel heat-clearing and toxic substances removing; Dispersing swelling and dissipating binds; Relieving stranguria by diuresis." Chinese herbal medicine is commonly used in Shanghai ": heat-clearing and toxic substances removing, diuresis.Control scrofula to steal, toxic swelling, venom, lithangiuria.
Herba Selaginellae Doederleinii: sweet in the mouth, micro-hardship, puckery, cool in nature.Return lung, Liver Channel.Heat-clearing and toxic substances removing, anticancer, hemostasis." national Chinese herbal medicine compilation ": heat-clearing and toxic substances removing, anticancer, hemostasis.Treating cancer, pneumonia, acute tonsillitis, eye conjunctivitis, mastitis.
Pseudobulbus Cremastrae Seu Pleiones: sweet, micro-pungent, cool.Return liver, spleen channel.Heat-clearing and toxic substances removing, dissipating phlegm and resolving masses.
" book on Chinese herbal medicine is newly organized ": " Pseudobulbus cremastrae seu pleiones is monarch in Yushu Dan, can controls strange illness.About strange illness is a lot of in expectorant, the medicine of the positive expectorant of Pseudobulbus cremastrae seu pleiones, controls expectorant and strange illness removes also certainly.Or the medicine of the non-expectorant of doubtful Pseudobulbus cremastrae seu pleiones, be the medicine of loose poison also.Do not know the non-Cheng Zhewei expectorant of poison, and the person of knot of expectorant being poison, is expectorant and poison, just cannot not two to look also.
Radix Glycyrrhizae: sweet, flat.GUIXIN, spleen, lung, stomach warp.Invigorating the spleen and replenishing QI, nourishing the lung to arrest cough, heat-clearing and toxic substances removing, alleviates pain relieving, relaxes the property of medicine.
Evil poison is tired for a long time easily enters network, gives adding Scolopendra dredging collateral and searching heresy, adds Radix Semiaquilegiae, Pseudobulbus Cremastrae Seu Pleiones, Herba Selaginellae Doederleinii assistant make Herba Scutellariae Barbatae, Herba Hedyotidis Diffusae heat-clearing and toxic substances removing eliminating stagnation; Full side plays supplementing QI and nourishing YIN altogether, blood stasis dispelling of eliminating the phlegm, detoxicating and resolving stagnation of pathogens effect, be adjuvant drug altogether.Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription, for making medicine.
The present invention's beneficial effect is compared with prior art:
The Chinese medicinal capsule of this nonsmall-cell lung cancer adopts 22 taste Chinese herbal medicine to make, utilize the comprehensive co-action for treating nonsmall-cell lung cancer of 22 taste crude drug, the Radix Astragali in the Chinese medicinal capsule of this nonsmall-cell lung cancer has the effects such as kinds of tumors propagation, infiltration, transfer such as suppressing pulmonary carcinoma, and has the effect of Tumor suppression new vessels; Herba Scutellariae Barbatae plays antitumor action mainly through the apoptosis of the propagation of mutation, inhibition tumor cell, inducing tumor cell, the immunity strengthening patient's body further, anti-ization and the nutrition supply etc. that blocks tumor cell.Herba Hedyotidis Diffusae has apoptosis-induced, Tumor suppression propagation to pulmonary carcinoma and lowers the effect of VEGF level, Radix Codonopsis extract is containing multiple Saponin and polysaccharide, be improved organism adaptation, enhancing human body immunity power, the effect of leukocyte increasing, Rhizoma Sparganii, Rhizoma Curcumae blood stasis dispelling become whole blood viscosity after changing life quality treatment, reduce transfer, promote that Chinese medicine medicine for preventing immunologically competent cell enters tumor body, thus reach anticancer and the effect of raising immunity.Full side is from the function of the internal organs of integrated regulation body, negative and positive, QI and blood and meridians, accomplish that what is called " is kept in healthy energy ", pass through self-regulation, " reducing for the excess syndrome; tonifying for deficiency syndrome ", reaches " negative and positive are calmed down ", and originally hyperfunction tumor-blood-vessel growth is suppressed, contribute to reducing the blood confession of tumor tissues local, prevent generation and the development of tumor.
In order to the curative effect of the present invention to treatment nonsmall-cell lung cancer is described, the present invention is through choosing 60 routine patients to this programme, and two group of 60 example all completed treatments, all can participate in evaluating.
1, front two groups of clinical data comparable situation are treated
1.1 liang of groups gender comparison (see table 1)
A table 1 liang group Gender situation compares
Note: through x
2inspection, x
2 =0.317 a p=0.389the expectation counting of > 0.05 a:0 cell (.0%) is less than 5. minimum expectations and is counted as 10.00
As can be seen from Table 2, two groups are compared in sex, through X 2 test, no significant difference (
p> is O.05), there is comparability.
1.2 liang of group ages compare (see table 2)
Table 2 liang group patient age constituent ratio comparatively (year)
Note: through t inspection, t=0.666,
p=0.508> 0.05
As can be seen from Table 3, in age structure, check through t for two groups, no significant difference (
p> is O.05), there is comparability.
1.3 liang of group histological type distribution situations compare (see table 3)
A table 3 liang group histological type distribution is compared (example)
Note: through x
2inspection, x
2=0.271
a,
p=0.397the expectation counting of > 0.05 a:0 cell (.0%) is less than 5. minimum expectations and is counted as 10.00
As can be seen from Table 4, two groups in histological type situation, through X 2 test, no significant difference (
p> is O.05), there is comparability.
1.4 liang of group clinical staging of lung cancer situations compare (see table 4)
A table 4 liang group clinical stages situation compares (example)
Note: through x
2inspection, x
2=0.067
a,
p=0.5the expectation counting of > 0.05 a:0 cell (.0%) is less than 5. minimum expectations and is counted as 10.00
As can be seen from Table 5, two groups in clinical stages situation, through X 2 test, no significant difference (
p> is O.05), there is comparability.
1.5 liang of group tcm clinical practice symptom integral situations compare (see table 5)
Front tcm clinical practice symptom integral situation for the treatment of table 5 compares (
± S)
Note: through the rank test of independent sample nonparametric
As can be seen from Table 6, two groups in TCM symptom score situation, through independent sample non parametric tests, no significant difference (
p> is O.05), there is comparability.
1.6 liang of group quality of life (Ka Shi) scoring situations compare (see table 6)
A table 6 liang group Ka Shi scoring is compared
Note: through rank test, Z=-0.998,
p=0.318> 0.05
As can be seen from Table 7, two groups in Ka Shi scoring, through rank test, no significant difference (
p> is O.05), there is comparability.
After 2 treatments, two groups of observation index situations compare
Before and after 2.1 treatments, Serum VEGF change is compared (see table 7)
Table 7 serum VEGF situation of change compares (
± S, pg/ml)
Note: through paired t-test, △ compares with before treatment, t=10.8,
p=0.000<0.05; ▲ compare with before treatment, t=2.4,
p=0.021<0.05;
Through independent samples t test, compares with matched group, t=-0.165,
p=0.87>0.05, ★ compares with matched group, t=-6.0,
p=0.000<0.05
As can be seen from Table 8,1. after two groups of treatments, Serum VEGF declines before all comparatively treat, ratio front with treatment, difference have statistical significance (
p<0.05); 2. treatment after treatment group Serum VEGF comparatively matched group is low, difference have statistical significance (
p<0.05).
The objective curative effect situation of 2.2 tumor compares (see table 8)
Rear two group object tumors change short-term evaluation situations treated by table 8
Note: through x
2inspection, *: with matched group ratio, x
2=2.498
a, ρ=0.114>0.05, #: with matched group ratio, x
2=4.365
a, ρ=0.037<0.05
The expectation counting of a:0 cell (.0%) is less than 5. minimum expectations and is counted as 10.00
As can be seen from Table 9, latter two groups for the treatment of is compared, through x in tumor near future curative effect
2inspection, effective percentage compares, no significant difference (
p>0.05), clinical Benefit rate compares, treatment group higher than matched group, difference have statistical significance (
p<0.05).
After 2.3 treatments, tcm symptom improvement situation compares (see table 9)
Table 9 is treated rear two groups of tcm symptoms and is improved situations
Note: through x
2inspection, *: with matched group ratio, x
2=4.8
a, ρ=0.028<0.05
The expectation counting of a:0 cell (.0%) is less than 5. minimum expectations and is counted as 10.00
As can be seen from Table 10, after treatment group treatment the total improvement rate of symptom comparatively the total improvement rate of matched group improve, through statistical test, difference have statistical significance (
p<0.05).
After 2.4 treatments, quality of life (Ka Shi scoring) situation of change compares (see table 10)
Situation that table 10 is treated rear quality of life (Kps scoring) compares (
± S)
Note: through x
2inspection, ▲: with matched group ratio, x
2=4.134
a, ρ=0.042<0.05
The expectation counting of a:0 cell (.0%) is less than 5. minimum expectations and is counted as 10.00
As can be seen from Table 11, treatment after the total improvement rate for the treatment of group comparatively matched group improve, difference have statistical significance (
p<0.05).
6 chemotherapy toxic side effects compare (see table 11, table 12)
Table 11 period 1 chemotherapy end toxicity situation compares (example)
After table 12 chemotherapy second round, toxicity situation compares (example)
As can be seen from table 11,12, two the cycle chemotherapy exist main toxicity be leukocyte reductions, platelet reduction, anemia, nausea and vomiting, constipation etc., be not in the mood for, Liver and kidney function exception and other toxicities; Two groups are compared in every toxicity, no significant difference (
p>0.05).
Three. conclusion
1. Fuzheng Kang tumor capsule associating GP scheme chemotherapy can reduce advanced NSCLC patients's Serum VEGF Expression level further.
2. the more simple GP scheme chemotherapy of Fuzheng Kang tumor capsule associating GP scheme chemotherapy improves patient clinical yield, improves tcm syndrome further, improves the quality of living.
Detailed description of the invention
Each raw material is got by above-mentioned weight portion:
The Radix Astragali 50 parts, Radix Codonopsis 20 parts, the Rhizoma Atractylodis Macrocephalae 15 parts,
15 parts, Poria, 15 parts, Fructus Jujubae, Ganoderma 30 parts,
Fructus Aurantii 12 parts, Semen Cuscutae 15 parts, Fructus Ligustri Lucidi 15 parts,
Fructus Lycii 15 parts, Endothelium corneum 30 parts, Semen Coicis 30 parts,
10 parts, Radix Glycyrrhizae, Herba Scutellariae Barbatae 30 parts, Rhizoma Sparganii 30 parts,
Rhizoma Curcumae 30 parts, Scolopendra 10 parts, Gekko Swinhonis 10 parts,
Radix Semiaquilegiae 15 parts, Herba Selaginellae Doederleinii 15 parts, Pseudobulbus Cremastrae Seu Pleiones 15 parts,
Herba Hedyotidis Diffusae 30 parts.
Capsule is made into by capsule filling machine after being shattered by above-mentioned 22 taste Chinese herbal medicine.
Usage and dosage: oral, one after each meal; One time 4 ~ 5, three times on the one.
Points for attention: anemia of pregnant woman is cautious use of.
The above is preferred embodiment of the present invention, above-mentioned illustrating does not do any pro forma restriction to flesh and blood of the present invention, any simple modification that person of an ordinary skill in the technical field has done above detailed description of the invention according to technical spirit of the present invention after having read this description or distortion, and the technology contents of above-mentioned announcement may be utilized to be changed or be modified to the Equivalent embodiments of equivalent variations, all still belong in the scope of technical solution of the present invention, and do not deviate from the spirit and scope of the invention.
Claims (1)
1. treat a Chinese medicinal capsule for nonsmall-cell lung cancer, it is characterized in that: it is made up of the raw material of following weight parts:
The Radix Astragali 50 parts, Radix Codonopsis 20 parts, the Rhizoma Atractylodis Macrocephalae 15 parts,
15 parts, Poria, 15 parts, Fructus Jujubae, Ganoderma 30 parts,
Fructus Aurantii 12 parts, Semen Cuscutae 15 parts, Fructus Ligustri Lucidi 15 parts,
Fructus Lycii 15 parts, Endothelium corneum 30 parts, Semen Coicis 30 parts,
10 parts, Radix Glycyrrhizae, Herba Scutellariae Barbatae 30 parts, Rhizoma Sparganii 30 parts,
Rhizoma Curcumae 30 parts, Scolopendra 10 parts, Gekko Swinhonis 10 parts,
Radix Semiaquilegiae 15 parts, Herba Selaginellae Doederleinii 15 parts, Pseudobulbus Cremastrae Seu Pleiones 15 parts,
Herba Hedyotidis Diffusae 30 parts;
In above-mentioned prescription: the Radix Astragali, Radix Codonopsis, the Rhizoma Atractylodis Macrocephalae, Poria, Fructus Jujubae is monarch drug; Ganoderma, Fructus Aurantii, Semen Cuscutae, Fructus Ligustri Lucidi, Fructus Lycii, Endothelium corneum, Semen Coicis, Herba Hedyotidis Diffusae, Herba Scutellariae Barbatae, Rhizoma Sparganii, Rhizoma Curcumae is ministerial drug; Scolopendra, Gekko Swinhonis, Radix Semiaquilegiae, Herba Selaginellae Doederleinii, Pseudobulbus Cremastrae Seu Pleiones is adjuvant drug; Radix Glycyrrhizae is for making medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510322226.8A CN104840905A (en) | 2015-06-12 | 2015-06-12 | Traditional Chinese medicine capsule for treating non-small cell lung cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510322226.8A CN104840905A (en) | 2015-06-12 | 2015-06-12 | Traditional Chinese medicine capsule for treating non-small cell lung cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104840905A true CN104840905A (en) | 2015-08-19 |
Family
ID=53841150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510322226.8A Pending CN104840905A (en) | 2015-06-12 | 2015-06-12 | Traditional Chinese medicine capsule for treating non-small cell lung cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104840905A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107281446A (en) * | 2017-06-30 | 2017-10-24 | 烟台市中医医院 | Treat the compound Chinese medicinal preparation of non-small cell lung cancer |
| CN108186994A (en) * | 2018-03-27 | 2018-06-22 | 张建安 | A kind of drug for preventing malignant tumour and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120109143A (en) * | 2011-03-28 | 2012-10-08 | 주식회사한국전통의학연구소 | Composition for treatment of lung cancer and functional food comprising extract of patriniae radix |
| CN103127443A (en) * | 2011-11-23 | 2013-06-05 | 周昌明 | Pharmaceutical composition for adjuvant therapy of cancers and preparation method thereof |
| CN104352887A (en) * | 2014-10-22 | 2015-02-18 | 安徽博格生物科技有限公司 | Anti-tumor comprehensive conditioning cream and preparing technology thereof |
-
2015
- 2015-06-12 CN CN201510322226.8A patent/CN104840905A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20120109143A (en) * | 2011-03-28 | 2012-10-08 | 주식회사한국전통의학연구소 | Composition for treatment of lung cancer and functional food comprising extract of patriniae radix |
| CN103127443A (en) * | 2011-11-23 | 2013-06-05 | 周昌明 | Pharmaceutical composition for adjuvant therapy of cancers and preparation method thereof |
| CN104352887A (en) * | 2014-10-22 | 2015-02-18 | 安徽博格生物科技有限公司 | Anti-tumor comprehensive conditioning cream and preparing technology thereof |
Non-Patent Citations (1)
| Title |
|---|
| 李永浩等: "扶正消瘤合剂治疗中晚期恶性肿瘤临床观察", 《时珍国医国药》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107281446A (en) * | 2017-06-30 | 2017-10-24 | 烟台市中医医院 | Treat the compound Chinese medicinal preparation of non-small cell lung cancer |
| CN107281446B (en) * | 2017-06-30 | 2021-11-23 | 烟台市中医医院 | Chinese medicinal compound preparation for treating non-small cell lung cancer |
| CN108186994A (en) * | 2018-03-27 | 2018-06-22 | 张建安 | A kind of drug for preventing malignant tumour and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101496893B (en) | Chinese medicinal composition for treating gall stone symptom and preparation method thereof | |
| CN103550517A (en) | Medicine for treating liver cancer | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN104547525A (en) | Drug composition for NSCLC (Non Small Cell Lung Cancer) prevention and preparation method thereof | |
| CN108524814A (en) | A kind of Chinese medicine composition and preparation method thereof for reducing blood glucose | |
| CN103520395B (en) | Traditional Chinese medicine composition for treating lung cancer | |
| CN102580000B (en) | Medicament for curing cancer pain and preparation method thereof | |
| CN102526498B (en) | Chinese medicine for eliminating toxic and side effects after nasopharyngeal carcinoma radiotherapy and preparation method and administration way thereof | |
| CN103550696B (en) | Medicine for treating lung cancer | |
| CN102526670B (en) | Traditional Chinese medicinal composition for treating cholecystitis and preparation method thereof | |
| CN104840905A (en) | Traditional Chinese medicine capsule for treating non-small cell lung cancer | |
| CN104083728B (en) | The processing method of anticancer dispersing tumor concentrated pill | |
| CN104547313B (en) | It is a kind of to treat lung cancer, breast cancer, the medicine of lymph cancer and preparation method | |
| CN102579999A (en) | Medicine for treating carcinous fever and preparation method thereof | |
| CN104784549A (en) | Traditional Chinese medicine for treating allergic rhinitis | |
| CN104189643A (en) | Osteopathia rehabilitation pill for treating chronic osteomyelitis | |
| CN103191399A (en) | Traditional Chinese medicine composition for treating bronchial asthma in acute-outbreak period | |
| CN105521246A (en) | Medicinal preparation for treating lung cancer and applications of medicinal preparation | |
| CN104998142A (en) | Medicament for treating cervical cancer and preparation method | |
| CN104547642A (en) | Tradtional Chinese medicine composition for treating female fibromyalgia syndromes | |
| CN102949679A (en) | Medicine for curing lung cancer and preparation method thereof | |
| CN102488804A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN102614466A (en) | Traditional Chinese medical preparation for treatment of lung adenocarcinoma | |
| CN105194484A (en) | Chinese herb preparation for preventing and treating ovarian cancer and preparation method | |
| CN101693096A (en) | Medicament for treating liver cancer and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150819 |
|
| RJ01 | Rejection of invention patent application after publication |